Biosimilar Therapeutic Peptides Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
TBRC’s market
report includes a chapter on the COVID-19 impact on the biosimilar therapeutic
peptides industry, which gives valuable insights on supply chain disruptions,
logistical challenges, and other economic implications of the virus on the
market and how companies can strategize to bounce back from it. With updated market
numbers according to the effects of the coronavirus, the report provides the
most accurate expected biosimilar therapeutic peptides market growth numbers
from 2022-2031.
Request a Sample of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3423&type=smp
The global biosimilar
therapeutic peptides market is expected to grow $0.93 billion in 2021 to $1.21
billion in 2022 at a compound annual growth rate (CAGR) of 30.3%. The growth in
the market is mainly due to the companies resuming their operations and
adapting to the new normal while recovering from the COVID-19 impact, which had
earlier led to restrictive containment measures involving social distancing,
remote working, and the closure of commercial activities that resulted in
operational challenges. The biosimilar therapeutic peptide market is expected
to reach $3.50 billion in 2026 at a CAGR of 30.3%.
View more on the report:
The Biosimilar
Therapeutic Peptides Global Market Report 2022-31 by The Business Research
Company evaluates biosimilar therapeutic peptides market size, growth rate,
drivers, biosimilar therapeutic peptides industry trends, and major companies.
The biosimilar
therapeutic peptides market segments in the report are:
1) By Route of
Administration: Parenteral Route, Transdermal Route, Others
2) By
Application: Cancer, Cardiovascular, Central Nervous System, Metabolic
Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders,
Dermatology, Respiratory Disorders
3) By Type:
Innovative, Generic
The table of contents in TBRC’s biosimilar therapeutic peptides market
report includes:
1. Executive Summary
2. Biosimilar
Therapeutic Peptides Market Characteristics
3. Biosimilar
Therapeutic Peptides Market Trends And Strategies
4. Impact Of
COVID-19 On Biosimilar Therapeutic Peptides
5. Biosimilar
Therapeutic Peptides Market Size And Growth.
.
28. Biosimilar
Therapeutic Peptides Pipeline Analysis
29. Key Mergers
And Acquisitions In The Biosimilar Therapeutic Peptides Market
30. Biosimilar
Therapeutic Peptides Market Future Outlook and Potential Analysis
31. Appendix
About The Business Research Company:
The Business
Research Company is a market intelligence firm that excels in company, market,
and consumer research. Located globally it has specialist consultants in a wide
range of industries including manufacturing, healthcare, financial services,
chemicals, and technology. It has offices in the UK, the US and India and
a network of trained researchers in 20+ countries globally.
Get a quick
glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
No comments:
Post a Comment